Helen Feilden

Helen Feilden serves as a Researcher at the Strathclyde Institute Of Pharmacy And Biomedical Sciences, University of Strathclyde, contributing to pharmaceutical research with expertise in engineering applications for medicine development. Her work spans multiple interdisciplinary domains at the intersection of chemical engineering and pharmaceutical sciences.

Her research focuses on Product Quality Engineering, Particle Size Chemistry, and Crystallization processes within pharmaceutical development. She specializes in applying digital design methodologies to optimize medicine manufacturing, with significant contributions to Robust Design Engineering, Predictive Capability systems, and Data Source integration for pharmaceutical applications. Her work addresses critical challenges in controlling particle attributes and ensuring consistent product quality through advanced process design.

Analysis of her publications reveals a strong trend toward integrating digital engineering principles with pharmaceutical manufacturing processes. Her research demonstrates how computational approaches can enhance control over crystallization and particle formation, leading to more reliable medicine production with improved sustainability profiles. This work has significant implications for accelerating drug development while maintaining rigorous quality standards.

Feilden has contributed to major collaborative research initiatives including the EPSRC-funded SMSdrug.net project (2011-2015), which aligned synthesis, medicinal chemistry, and structural genomics to accelerate UK drug discovery. Her collaborative network spans multiple academic and research institutions, reflecting the interdisciplinary nature of modern pharmaceutical development.